Serum EVs-Derived miRNA-105-5p Fosters ESCC Cell Growth In Vivo Through Targeting SPARCL1 and Regulating FAK/Akt Signaling Pathway. This evidence concerns the gene SPARCL1 and esophageal squamous cell carcinoma.